Cyclera Therapeutics
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cyclera Therapeutics - overview
Location
Seattle, WA, US
Primary Industry
Biotechnology
About
Based in Washington, US, Cyclera Therapeutics, operates as a therapeutics research company aiming to find treatments for cancer and CNS diseases. Cyclera Therapeutics raised venture funding from investor Argonautic Ventures. The company offers healthcare service solutions that include treatments for cancer and CNS diseases. The company’s products include CYpHER, potent targeted protein degradation technology uniquely designed for extracellular drivers of disease.
Current Investors
Argonautic Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biotechnology, Pharmaceutical Research & Development
Website
https://cycleratx.com/
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.